Skip to content
★ Sign in to follow
JF

John F. Rothman

Advaxis, Inc.
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€24k
▼ Sales (0 ops.)
—

Latest filing published 30 Oct 2007 for Advaxis, Inc., €7,634.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

John F. Rothman: trading record in brief

John F. Rothman appears in our data through filings on Advaxis, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 23 February 2007 and the latest from 25 October 2007.

Every open-market trade on record is a purchase: 2 purchases worth €24k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The latest filing, published on 30 October 2007, reports an open-market purchase of €7,634 in Advaxis, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to John F. Rothman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    VP Clinical DevelopmentExecutivesAdvaxis, Inc.
    10,988 USD0SEC
    61,043 shares@ US$0.18Common StockSEC:0001144204-07-057007:0
    Canonical exit: 23 Jan 2008 (T+90)
  • ▲
    VP of Clinical DevelopmentExecutivesAdvaxis, Inc.
    21,557 USD0SEC
    134,732 shares@ US$0.16Common StockSEC:0001144204-07-010626:0
    Canonical exit: 24 May 2007 (T+90)

2 of 2 declarations